Source:http://linkedlifedata.com/resource/pubmed/id/21402930
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2011-3-30
|
pubmed:databankReference | |
pubmed:abstractText |
The human malaria parasite Plasmodium falciparum can cause infected red blood cells (iRBC) to form rosettes with uninfected RBC, a phenotype associated with severe malaria. Rosetting is mediated by a subset of the Plasmodium falciparum membrane protein 1 (PfEMP1) variant adhesins expressed on the infected host-cell surface. Heparin and other sulfated oligosaccharides, however, can disrupt rosettes, suggesting that therapeutic approaches to this form of severe malaria are feasible. We present a structural and functional study of the N-terminal domain of PfEMP1 from the VarO variant comprising the N-terminal segment (NTS) and the first DBL domain (DBL1?(1)), which is directly implicated in rosetting. We demonstrate that NTS-DBL1?(1)-VarO binds to RBC and that heparin inhibits this interaction in a dose-dependent manner, thus mimicking heparin-mediated rosette disruption. We have determined the crystal structure of NTS-DBL1?(1), showing that NTS, previously thought to be a structurally independent component of PfEMP1, forms an integral part of the DBL1? domain. Using mutagenesis and docking studies, we have located the heparin-binding site, which includes NTS. NTS, unique to the DBL ?-class domain, is thus an intrinsic structural and functional component of the N-terminal VarO domain. The specific interaction observed with heparin opens the way for developing antirosetting therapeutic strategies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1091-6490
|
pubmed:author |
pubmed-author:BaronBrunoB,
pubmed-author:BentleyGraham AGA,
pubmed-author:EnglandPatrickP,
pubmed-author:GangnardStéphaneS,
pubmed-author:GuillotteMichelineM,
pubmed-author:HesselAudreyA,
pubmed-author:JuilleratAlexandreA,
pubmed-author:Lewit-BentleyAnitaA,
pubmed-author:Mercereau-PuijalonOdileO,
pubmed-author:Vigan-WomasInèsI
|
pubmed:issnType |
Electronic
|
pubmed:day |
29
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5243-8
|
pubmed:dateRevised |
2011-9-30
|
pubmed:meshHeading |
pubmed-meshheading:21402930-Amino Acid Sequence,
pubmed-meshheading:21402930-Crystallography, X-Ray,
pubmed-meshheading:21402930-Erythrocytes,
pubmed-meshheading:21402930-Heparin,
pubmed-meshheading:21402930-Humans,
pubmed-meshheading:21402930-Models, Molecular,
pubmed-meshheading:21402930-Molecular Sequence Data,
pubmed-meshheading:21402930-Mutation,
pubmed-meshheading:21402930-Plasmodium falciparum,
pubmed-meshheading:21402930-Protein Structure, Tertiary,
pubmed-meshheading:21402930-Protozoan Proteins,
pubmed-meshheading:21402930-Rosette Formation
|
pubmed:year |
2011
|
pubmed:articleTitle |
Structure of a Plasmodium falciparum PfEMP1 rosetting domain reveals a role for the N-terminal segment in heparin-mediated rosette inhibition.
|
pubmed:affiliation |
Institut Pasteur, Unité d'Immunologie Structurale, 75015 Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|